Bellerophon Therapeutics (BLPH) Fails to deliver data

Key failure to deliver metrics for Bellerophon Therapeutics :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bellerophon Therapeutics (BLPH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bellerophon Therapeutics (BLPH) - since 2020

Bellerophon Therapeutics (BLPH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	€11.62 M	€53.13 M	🇺🇸 USA
Abeona Therapeutics ABEO	€0.03 M	€1.41 M	🇺🇸 USA
Abbott Laboratories ABT	€24.54 M	€0.13 B	🇺🇸 USA
Lantheus Holdings LNTH	€1.79 M	€13.34 M	🇺🇸 USA